Can I read Tricuspid Valve Replacement Outcomes by Baseline Tricuspid Regurgitation Severity Triscend 2 on EtoBox?

Tricuspid Valve Replacement Outcomes by Baseline Tricuspid Regurgitation Severity Triscend 2 by nievas.pm is a document available to read on EtoBox.

What is Tricuspid Valve Replacement Outcomes by Baseline Tricuspid Regurgitation Severity Triscend 2 about?

The TRISCEND II trial evaluated the outcomes of transcatheter tricuspid valve replacement (TTVR) in patients with severe tricuspid regurgitation (TR), showing significant clinical benefits compared to medical therapy alone. One year post-procedure, 95% of patients experienced a reduction in TR severity, with TTVR demonstrating favorable safety and effectiveness across different baseline TR severities. The study indicates that TTVR is beneficial for patients with severe TR, particularly those with more advan

Author

nievas.pm

Language

EN